FDA Approves Leucovorin for Rare Disorder, Not Autism

0:00On this March 10th, here's what's shaping the world. The Food and Drug Administration approved a generic form of the drug lucovorin on Tuesday for a rare genetic condition that blocks folate from, reaching the brain. This ultra-rare disorder affects fewer than 1 in a million Americans and causes seizures, movement issues, and other neurological problems. Earlier this month, President Trump and top officials touted the drug's potential for autism during a White House event. They suggested it could help 20 to 50% of kids with autism who might have similar folate issues. FDA leaders clarified they narrowed their review to the strongest evidence, which only backs use for this specific rare mutation. They also noted a key study supporting autism treatment was pulled earlier this year. Prescriptions for the drug and children aged 5 to 17 surged 71% right after the announcement. Families have faced shortages, prompting the FDA to allow imports from foreign makers since the original producer has

1:01no plans to restart. Medical experts remain cautious with groups like the American Academy of Pediatrics not recommending routine use for autism. Most research points to genetics and environment as main factors in the condition. DNN is sponsored by our partner. Podcasts hit different when the sound comes from your pillow. Once you try it, it just makes sense as so, L-I-SOLYPILLOW.COM